Back to today’s briefing

Story perspectives

Gene-Editing Breakthrough at Risk Amid NIH Funding Cuts

5/29/2025

47 6

Summary

Story summary

Dr. Rebecca Ahrens-Nicklas has pioneered a revolutionary gene-editing therapy for a child battling a rare disorder, highlighting the critical role of physician-scientists. However, looming NIH funding cuts jeopardize not only future innovations but also the essential training of these dedicated professionals who connect clinical needs with scientific breakthroughs.

1 of 1

Story summary

Dr. Rebecca Ahrens-Nicklas has pioneered a revolutionary gene-editing therapy for a child battling a rare disorder, highlighting the critical role of physician-scientists. However, looming NIH funding cuts jeopardize not only future innovations but also the essential training of these dedicated professionals who connect clinical needs with scientific breakthroughs.